LineaRx, an Applied DNA Sciences, Inc. company, delivers enzymatically-produced LineaDNA™ as an alternative to current plasmid-based DNA manufacturing processes with advantages of speed, purity and scalability to support the next generation of nucleic acid-based therapies. Produced using a proprietary, large-scale polymerase chain reaction (“PCR”) based manufacturing platform, LineaDNA allows for the rapid and efficient cell-free production of high-fidelity DNA sequences.
mRNA/IVT Templates
efficient mRNA synthesis begins with robust, high-quality LineaRx production solutions
DNA Vaccines
DNA vaccine development relies on the rapid generation of high-purity DNA
Gene Editing
high-precision DNA is paramount for successful gene editing applications
Personalized Medicine
in the era of personalized medicine, tailored therapies require the rapid production of custom DNA sequences